SpaceX Stock Is Down 22% From Its Peak. History Says This Is How Low It Will Go -- and What Comes Next.

SpaceX shares are down ~22% from their post-IPO peak, after a history-matched initial surge of ~19% on day one. While upcoming Nasdaq-100 inclusion (effective after the July 6, 2026 close) could support the rebound, insider selling risk is elevated: after the Q2 earnings update (mid-August), ~20% of eligible insider shares become sellable (rising by an additional 10% if the stock trades 30% above the IPO for 5 of 10 days), with further lockup expirations up to 28% more after Q3. Based on prior major IPO patterns, the article suggests the stock could decline nearly 30% from current levels, citing a valuation mismatch versus $18.7B in last-year revenue despite $2.2T+ market cap.

Analysis

The first-order move is mechanical: index-inclusion demand can support price for a few sessions, but it is not a durable clearing bid. The more important setup is supply: when lockup windows open, the marginal seller is typically informed, size-sensitive, and willing to sell into strength, which means the stock can gap down faster than it rallied if momentum buyers are late. That creates a classic “good news → worse liquidity” sequence over the next 1-3 months, especially if the stock is already stretched versus revenue scale.

For competitors and proxies, the main spillover is valuation anchoring. A richly priced, high-profile space/EV/AI-like listing tends to pull multiple expectations upward briefly, then compress the whole cohort when the market re-prices growth against hard dilution and insider supply; that is a mild negative for TSLA and a stronger negative for RIVN, which already trades more as a sentiment barometer than a fundamentals story. NDAQ may see a short-lived volume and inclusion-related benefit, but that is low-quality revenue and should fade once the rebalancing trade is complete.

Contrarian view: the consensus is overweighting the Nasdaq-100 effect and underweighting the fact that passive demand is finite while supply is recurring. The real risk is not just a 20-30% air pocket; it is a longer de-rating cycle if subsequent quarters fail to justify the post-IPO multiple, because every insider sale after the first wave becomes a fresh signal that early holders prefer liquidity over upside. What would falsify the bearish thesis is sustained post-lockup price strength on rising volume without a spike in insider selling, or a credible upward revision in forward revenue growth that narrows the valuation gap materially within one earnings cycle.

Key Decisions for Investors

• If SPCX is tradable, fade the post-inclusion strength: short SPCX into the Nasdaq-100 rebalance window and cover into the first 3-5 sessions after forced index buying peaks; target a 10-15% downside retrace with a tight stop above the recent breakout high.
• Pair trade: long NDAQ / short SPCX for the 2-6 week event window. NDAQ captures the structural increase in index-trading volumes while capping direct fundamental risk; the short leg should outperform if the market starts discounting lockup-driven supply.
• Use TSLA or RIVN as high-beta proxy hedges against a broader de-rating in speculative growth multiples. Prefer RIVN short over TSLA if the goal is pure multiple compression exposure; RIVN has less balance-sheet cushion and historically higher beta to sentiment air pockets.
• Set an alert for insider-sale disclosures and any acceleration in secondary supply after the Q2 update. If eligible insiders sell aggressively and the stock fails to hold the 50-day moving average, treat that as confirmation of a 1-3 month distribution phase.
• For patient capital, avoid initiating fresh longs until after the first post-lockup sell window passes and the stock trades on fundamental numbers rather than float scarcity; the risk/reward is better on the other side of supply overhang.